Tayyab Khan

643 total citations
27 papers, 294 citations indexed

About

Tayyab Khan is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tayyab Khan has authored 27 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tayyab Khan's work include Bone health and osteoporosis research (5 papers), Bone health and treatments (4 papers) and Parathyroid Disorders and Treatments (4 papers). Tayyab Khan is often cited by papers focused on Bone health and osteoporosis research (5 papers), Bone health and treatments (4 papers) and Parathyroid Disorders and Treatments (4 papers). Tayyab Khan collaborates with scholars based in Canada, United States and United Kingdom. Tayyab Khan's co-authors include Lisa-Ann Fraser, Kristin K. Clemens, Tharsan Kanagalingam, Nabil Sultan, Christina Holmes, Marc D. Grynpas, Celeste Owen, Subodh Verma, Harpreet S. Bajaj and William L. Stanford and has published in prestigious journals such as Journal of Bone and Mineral Research, The Annals of Thoracic Surgery and American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.

In The Last Decade

Tayyab Khan

22 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tayyab Khan Canada 10 83 76 63 59 55 27 294
Ruifei Yang China 6 79 1.0× 74 1.0× 71 1.1× 84 1.4× 41 0.7× 10 313
Karel David Belgium 9 49 0.6× 60 0.8× 71 1.1× 31 0.5× 30 0.5× 23 256
H. A. Sørensen Denmark 11 82 1.0× 77 1.0× 48 0.8× 58 1.0× 62 1.1× 14 326
Leland Graves United States 12 49 0.6× 113 1.5× 63 1.0× 80 1.4× 63 1.1× 28 389
T. Miki Japan 9 70 0.8× 109 1.4× 27 0.4× 80 1.4× 80 1.5× 16 383
Rebecca D. Murray United States 7 79 1.0× 53 0.7× 40 0.6× 25 0.4× 34 0.6× 9 325
Sandra Williams United States 4 155 1.9× 66 0.9× 162 2.6× 80 1.4× 56 1.0× 6 352
Daiki Nakaoka Japan 8 120 1.4× 168 2.2× 142 2.3× 85 1.4× 109 2.0× 8 429
S Czekalski Poland 9 144 1.7× 62 0.8× 118 1.9× 53 0.9× 40 0.7× 41 404
Susan T. Haden United States 7 47 0.6× 75 1.0× 109 1.7× 40 0.7× 31 0.6× 8 326

Countries citing papers authored by Tayyab Khan

Since Specialization
Citations

This map shows the geographic impact of Tayyab Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tayyab Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tayyab Khan more than expected).

Fields of papers citing papers by Tayyab Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tayyab Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tayyab Khan. The network helps show where Tayyab Khan may publish in the future.

Co-authorship network of co-authors of Tayyab Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Tayyab Khan. A scholar is included among the top collaborators of Tayyab Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tayyab Khan. Tayyab Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldenberg, Ronald, Jeremy Gilbert, Robyn L. Houlden, et al.. (2025). Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms. Current Medical Research and Opinion. 41(3). 403–419. 1 indexed citations
2.
Khan, Tayyab, et al.. (2025). Trends in Alzheimer's‐Related Mortality Among Type 2 Diabetes Patients in the United States: 1999–2019. Endocrinology Diabetes & Metabolism. 8(2). e70032–e70032. 2 indexed citations
3.
Sohail, Muhammad Umer, et al.. (2025). Trends and Disparities in Diabetes Mellitus and Atrial fibrillation Related Mortality in the United States: 1999–2020. Diabetes Research and Clinical Practice. 223. 112112–112112. 4 indexed citations
4.
Moroney, Michael, Joseph R. Casey, Tayyab Khan, et al.. (2025). Emerging Implications of Elevated Lipoprotein(a) Levels in Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery. 120(1). 167–176.
5.
Khan, Tayyab, et al.. (2025). Safety and Efficacy of Protamine in Heparin Reversal After Transcatheter Aortic Valve Replacement. American Journal of Therapeutics. 32(6). e598–e600.
6.
Houlden, Robyn L., Jeremy Gilbert, Tayyab Khan, et al.. (2025). Perioperative and Periprocedural Management of Once-Weekly Insulin Treated Patients. Endocrine Practice. 31(5). 699–702.
7.
Bhatt, Deepak L., Adrian Quan, Yi Pan, et al.. (2024). Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial. Med. 5(7). 718–734.e4. 6 indexed citations
8.
Khan, Tayyab, et al.. (2023). Bones of contention: Predicting and preventing fractures in patients receiving peritoneal dialysis. Peritoneal Dialysis International. 43(4). 286–291.
9.
Kanagalingam, Tharsan, et al.. (2023). Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative. Archives of Osteoporosis. 18(1). 138–138. 1 indexed citations
10.
Khan, Tayyab, Partha Sinha, & Harold N. Rosen. (2023). To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday. Cleveland Clinic Journal of Medicine. 90(3). 173–180. 2 indexed citations
11.
Khan, Aliya, Zubin Punthakee, Muhammad Shrayyef, et al.. (2021). Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada. Endocrine. 72(2). 553–561. 16 indexed citations
12.
Kanagalingam, Tharsan, et al.. (2021). Denosumab in chronic kidney disease: a narrative review of treatment efficacy and safety. Archives of Osteoporosis. 16(1). 116–116. 31 indexed citations
13.
Jeyakumar, Nivethika, Eric McArthur, Jamie L Fleet, et al.. (2020). Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study. Journal of Bone and Mineral Research. 38(5). 650–658. 18 indexed citations
14.
Clemens, Kristin K., et al.. (2020). Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study. Archives of Osteoporosis. 15(1). 133–133. 6 indexed citations
15.
Bajaj, Harpreet S., Amel Arnaout, Mohamed Hassanein, et al.. (2018). Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During Ramadan. Canadian Journal of Diabetes. 43(1). 3–12. 38 indexed citations
16.
Khan, Tayyab, et al.. (2015). Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis.. PubMed. 36(8). 745–9. 15 indexed citations
17.
LeVan, Pierre, et al.. (2014). Current Use of Ultrasound Transmission Gel for Transesophageal Echocardiogram Examinations: A Survey of Cardiothoracic Anesthesiology Fellowship Directors. Journal of Cardiothoracic and Vascular Anesthesia. 28(5). 1208–1210. 4 indexed citations
18.
19.
Walter, James S., C.J. Robinson, Tayyab Khan, John S. Wheeler, & Robert D. Wurster. (1989). Sacral Epidural Electrodes for Voiding in the Chronic Spinal Dog. Stereotactic and Functional Neurosurgery. 53(2). 113–124. 6 indexed citations
20.
Khan, Tayyab, et al.. (1987). Effect of injury on nerve growth factor uptake by sensory ganglia. Journal of Neuroscience Research. 18(4). 562–567. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruifei Yang Breakdown of academic impact, for papers by Karel David Breakdown of academic impact, for papers by H. A. Sørensen Breakdown of academic impact, for papers by Leland Graves Breakdown of academic impact, for papers by T. Miki Breakdown of academic impact, for papers by Rebecca D. Murray Breakdown of academic impact, for papers by Sandra Williams Breakdown of academic impact, for papers by Daiki Nakaoka Breakdown of academic impact, for papers by S Czekalski Breakdown of academic impact, for papers by Susan T. Haden
Rankless by CCL
2026